ArticleFrontiers in psychiatry2026
Beyond single-person paradigms: N400 alterations in a social context in schizophrenia.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Impairments in social cognition and context-dependent information processing constitute prominent features of schizophrenia. Among event-related potentials (ERPs), the N400 is known to be sensitive to semantic and social contextual information. However, its role in social contexts has received limited attention in schizophrenia research, as previous studies have largely examined the N400 in isolated, single-person paradigms or have focused on the P300 component. Methods: In this study, we examined the N400 ERP component in a real-world social context using EEG hyperscanning. Patients with schizophrenia (SZ; N = 34) and healthy controls (HC; N = 48) performed an actor-observer Go/NoGo task in pairs using the International Affective Picture System (IAPS) with emotionally valenced and neutral images. The task was repeated, with participants switching roles, and analyses were restricted to the actor condition at fronto-central electrodes. Clinical symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS). Although our analysis focused on the N400, we also examined the P300 amplitude, given the functional relationship between these components during information processing. Results: Primary analysis revealed significantly reduced N400 amplitudes in patients with schizophrenia compared with healthy controls, both across all stimuli and specifically in response to negative and positive stimuli. With second stimulus exposure, N400 amplitudes remained stable in healthy controls but showed a significant decline in the schizophrenia group. During the second exposure, higher PANSS total scores and higher scores on the negative and general psychopathology subscales were significantly associated with attenuated N400 amplitudes, whereas lower levels of psychopathology were associated with a polarity reversal. Secondary analyses revealed significantly reduced P300 amplitudes in patients with schizophrenia for positive stimuli and for all stimulus-valences combined. With second exposure, P300 amplitudes increased in the schizophrenia group, whereas they decreased in healthy controls. Discussion: The observed alterations in N400 responses indicate that impairments in context-dependent affective information processing in schizophrenia extend to social context. Alterations in the P300 component may further reflect deficits in cognitive control and response inhibition. Collectively, these findings suggest a dysfunction in neural processes responsible for monitoring and resolving mismatches between internal predictions and social contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.